CorMedix (CRMD) Operating Income Growth (3y) (2013 - 2025)
CorMedix (CRMD) Operating Income Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | - |
| 10 | CorMedix | 5.17 Mn | -150.03 Mn | 107.31 Mn | 108.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 108.38% |
| Sep 30, 2025 | 110.86% |
| Jun 30, 2025 | 63.51% |
| Mar 31, 2025 | 69.41% |
| Dec 31, 2024 | 54.15% |
| Sep 30, 2024 | 27.33% |
| Jun 30, 2024 | -37.53% |
| Mar 31, 2024 | -32.32% |
| Dec 31, 2023 | -37.07% |
| Sep 30, 2023 | -16.60% |
| Jun 30, 2023 | -9.79% |
| Mar 31, 2023 | -25.22% |
| Dec 31, 2022 | -15.99% |
| Sep 30, 2022 | -10.42% |
| Jun 30, 2022 | -14.17% |
| Mar 31, 2022 | -12.62% |
| Dec 31, 2021 | -77.99% |
| Sep 30, 2021 | 5.78% |
| Jun 30, 2021 | 11.80% |
| Mar 31, 2021 | 10.89% |